(VIANEWS) – The NASDAQ ended the session with Pacific Biosciences of California rising 13.22% to $6.12 on Saturday, after two consecutive sessions in a row of gains. NASDAQ jumped 3.33% to $12,131.13, after two consecutive sessions in a row of gains, on what was a very up trend exchanging session today.

Volume

Today’s last reported volume for Pacific Biosciences of California is 5554550, 14.06% below its average volume of 6463390.

Pacific Biosciences of California’s last close was $5.41, 85.12% under its 52-week high of $36.36.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 17% for the ongoing quarter and 30.3% for the next. The company’s growth estimates for the current quarter and the next is a negative 57.1% and a negative 500%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 130.51M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pacific Biosciences of California’s stock is considered to be overbought (>=80).

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $6.12 at 00:36 EST, way below its 52-week high of $36.36 and way higher than its 52-week low of $4.51.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s value is way under its 50-day moving average of $7.81 and way under its 200-day moving average of $18.13.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here